Search details
1.
IGFBP7 is not required for B-RAF-induced melanocyte senescence.
Cell
; 141(4): 717-27, 2010 May 14.
Article
in English
| MEDLINE | ID: mdl-20478260
2.
Genomic and proteomic findings in early melanoma and opportunities for early diagnosis.
Exp Dermatol
; 32(2): 104-116, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36373875
3.
Whole-genome landscapes of major melanoma subtypes.
Nature
; 545(7653): 175-180, 2017 05 11.
Article
in English
| MEDLINE | ID: mdl-28467829
4.
Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene.
Genes Chromosomes Cancer
; 51(5): 452-61, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22250051
5.
A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration.
BMC Genomics
; 13: 677, 2012 Nov 28.
Article
in English
| MEDLINE | ID: mdl-23190615
6.
Cross-Platform Omics Prediction procedure: a statistical machine learning framework for wider implementation of precision medicine.
NPJ Digit Med
; 5(1): 85, 2022 Jul 04.
Article
in English
| MEDLINE | ID: mdl-35788693
7.
Familial concordance of breast cancer pathology as an indicator of genotype in multiple-case families.
Genes Chromosomes Cancer
; 49(12): 1082-94, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-20815029
8.
Is MSH2 a breast cancer susceptibility gene?
Fam Cancer
; 7(2): 151-5, 2008.
Article
in English
| MEDLINE | ID: mdl-17922223
9.
BCoR-L1 variation and breast cancer.
Breast Cancer Res
; 9(4): R54, 2007.
Article
in English
| MEDLINE | ID: mdl-17697391
10.
Clinical significance of intronic variants in BRAF inhibitor resistant melanomas with altered BRAF transcript splicing.
Biomark Res
; 5: 17, 2017.
Article
in English
| MEDLINE | ID: mdl-28503307
11.
PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors.
Clin Cancer Res
; 23(20): 6054-6061, 2017 Oct 15.
Article
in English
| MEDLINE | ID: mdl-28724663
12.
Variation in the RAD51 gene and familial breast cancer.
Breast Cancer Res
; 8(3): R26, 2006.
Article
in English
| MEDLINE | ID: mdl-16762046
13.
Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource.
Breast Cancer Res
; 8(1): R12, 2006.
Article
in English
| MEDLINE | ID: mdl-16507150
14.
Dominant negative ATM mutations in breast cancer families.
J Natl Cancer Inst
; 94(3): 205-15, 2002 Feb 06.
Article
in English
| MEDLINE | ID: mdl-11830610
15.
Comparison of whole-exome sequencing of matched fresh and formalin fixed paraffin embedded melanoma tumours: implications for clinical decision making.
Pathology
; 48(3): 261-6, 2016 Apr.
Article
in English
| MEDLINE | ID: mdl-27020503
16.
Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer.
Breast Cancer Res
; 7(6): R1005-16, 2005.
Article
in English
| MEDLINE | ID: mdl-16280053
17.
Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.
Oncotarget
; 6(29): 27023-36, 2015 Sep 29.
Article
in English
| MEDLINE | ID: mdl-26304929
18.
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms.
Eur J Cancer
; 51(18): 2792-9, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26608120
19.
Tumour procurement, DNA extraction, coverage analysis and optimisation of mutation-detection algorithms for human melanoma genomes.
Pathology
; 47(7): 683-93, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26517638
20.
Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients.
Pigment Cell Melanoma Res
; 27(6): 1106-16, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-24995518